Jonathan E. Alpert, M.D., Ph.D.

Original Research

Serum Folate, Vitamin B12, and Homocysteine in Major Depressive Disorder, Part 2: Predictors of Relapse During the Continuation Phase of Pharmacotherapy

August 16, 2004

Original Research

Serum Folate, Vitamin B12, and Homocysteine in Major Depressive Disorder, Part 1: Predictors of Clinical Response in Fluoxetine-Resistant Depression

August 16, 2004

Original Research

Gepirone Extended-Release Treatment of Anxious Depression: Evidence From a Retrospective Subgroup Analysis in Patients With Major Depressive Disorder

August 16, 2004

Original Research

Somatic Symptoms as Predictors of Time to Onset of Response to Fluoxetine in Major Depressive Disorder

April 1, 2004

Original Research

Ziprasidone Augmentation of Selective Serotonin Reuptake Inhibitors (SSRIs) for SSRI-Resistant Major Depressive Disorder

February 1, 2004

Original Research

Psychiatric Comorbidity as a Predictor of Clinical Response to Nortriptyline in Treatment-Resistant Major Depressive Disorder

November 15, 2003

DELETE Current Perspectives in the Treatment of Depression

Prevention of Relapse and Recurrence in Depression: The Role of Long-Term Pharmacotherapy and Psychotherapy

October 1, 2003

DELETE Current Perspectives in the Treatment of Depression

Prevention of Relapse and Recurrence in Depression: The Role of Long-Term Pharmacotherapy and Psychotherapy

October 1, 2003

Original Research

Nortriptyline for Treatment-Resistant Depression

January 15, 2003

Original Research

Efficacy of Fluvoxamine in the Treatment of Major Depression With Comorbid Anxiety Disorders

September 30, 1999

Original Research

Residual Symptoms in Depressed Patients Who Respond Acutely to Fluoxetine

April 30, 1999

Article

Course and Treatment of Atypical Depression

February 1, 1998